ABREPTOR Trademark

Trademark Overview


On Thursday, September 19, 2024, a trademark application was filed for ABREPTOR with the United States Patent and Trademark Office. The USPTO has given the ABREPTOR trademark a serial number of 98759550. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 19, 2024. This trademark is owned by Pinetree Therapeutics, Inc.. The ABREPTOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals for others; Research and development of pharmaceuticals for others related to cancer, infectious diseases, and viral related diseases and disorders; Research and development of substances containing multispecific anyibodies for degrading receptors and extracellular proteins; Medical research; Medical laboratories; Medical and scientific research in the field of cancer, infectious diseases, and viral related diseases and disorders; Clinical research in the field of cancer, infectious diseases, and viral related diseases and disorders; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Compiling data for research purposes in the field of medical science and medical consultancy
abreptor

General Information


Serial Number98759550
Word MarkABREPTOR
Filing DateThursday, September 19, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and development of pharmaceuticals for others; Research and development of pharmaceuticals for others related to cancer, infectious diseases, and viral related diseases and disorders; Research and development of substances containing multispecific anyibodies for degrading receptors and extracellular proteins; Medical research; Medical laboratories; Medical and scientific research in the field of cancer, infectious diseases, and viral related diseases and disorders; Clinical research in the field of cancer, infectious diseases, and viral related diseases and disorders; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Compiling data for research purposes in the field of medical science and medical consultancy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePinetree Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events


Event DateEvent Description
Thursday, September 19, 2024NEW APPLICATION ENTERED